Not in our crash carts. Has not been in carts for 30+ years.
***********************************************************************************************
Thomas P Lombardi, BS, PharmD, RPh, FASHP
System Director of Pharmacy
Chair, Institutional Review Board
O 518.525.1266 F 518.525.1917
Private Fax 518-944-2365
Thomas.lombardi@xxxxxxxx<mailto:Thomas.lombardi@xxxxxxxx>
St. Peter’s Health Partners
315 S. Manning Blvd
Albany, New York 12208
[Description: Description: cid:image001.jpg@01CD6316.50EE3070]
For information about the PGY-1 Pharmacy Residency Program:
Website: www.sphcs.org/prp<http://www.sphcs.org/prp>
CONFIDENTIALITY NOTICE: This e-mail, including attachments, is for the sole
purpose of the individual to whom it is addressed, and may contain confidential
and privileged information. Any unauthorized review , use, disclosure, or
distribution is prohibited. If you have received this e-mail in error, please
notify the sender by reply e-mail and destroy this message and its attachments.
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Bernard E. Delello
Sent: Wednesday, December 07, 2016 1:50 PM
To: nyschp.dop@xxxxxxxxxxxxx
Subject: [External] [nyschp.dop] Re: ***External Email***Re: Isoprel in crash
carts [SEC=UNOFFICIAL]
Not in our crash carts either.
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Robert DiGregorio
Sent: Wednesday, December 07, 2016 1:13 PM
To: nyschp.dop@xxxxxxxxxxxxx
Subject: ***External Email***[nyschp.dop] Re: Isoprel in crash carts
[SEC=UNOFFICIAL]
We removed this from crash carts 15 years ago.
________________________________
From: Sandra Obleman
<sobleman@xxxxxxxxxxxxxxxx<mailto:sobleman@xxxxxxxxxxxxxxxx>>
Date: December 7, 2016 at 10:07:25 AM PST
To: nyschp.dop@xxxxxxxxxxxxx<mailto:nyschp.dop@xxxxxxxxxxxxx>
<nyschp.dop@xxxxxxxxxxxxx<mailto:nyschp.dop@xxxxxxxxxxxxx>>
Subject: [nyschp.dop] Isoprel in crash carts
Hi Everyone,
We are at the point that our Isoprel is going to out date and will need
replaced in our crash carts? As you all know it is very expensive and before I
order more I would like to know has anyone out there removed it from their
crash carts? I do not know how anyone could afford to keep this on formulary.
Thanks
Sandy
Sandra Obleman, Pharm.D.
Director of Pharmacy|Oswego Health
110 West Sixth Street | Oswego, NY 13126
office: 315-349-5719
e-mail: sobleman@xxxxxxxxxxxxxxxx<mailto:sobleman@xxxxxxxxxxxxxxxx>
[cid:image001.jpg@01D1F19C.46BA4620]<https://linkprotect.cudasvc.com/url?a=http://www.oswegohealth.org/&c=E,1,yArsV7loXFTAchCvkl6Gh6ndEgVDo_UKPCnDHn86Ci6LoECWLgBkHZeW44UKGa6w25U7MqSUf2_2nkOrkKrrG5bTCUcp8uIs4G5DoBpca8olm-Vy&typo=1>
[Image removed by sender.] [Image removed by sender.]
________________________________
This communication is from Oswego Health, Inc., or an affiliate, and is
intended solely for the use of the individual or entity to which it is
addressed. Information contained herein may include privileged and/or
confidential information. Unauthorized review, forwarding, printing, copying,
distributing or using such information is strictly prohibited and may be
unlawful. If you received this message in error or if you are otherwise
unauthorized to receive it, please promptly return to sender via email with a
copy to
privacyofficer@xxxxxxxxxxxxxxxx<mailto:privacyofficer@xxxxxxxxxxxxxxxx>, then
delete the original message and destroy all copies. Thank you.
This electronic message is intended to be for the use only of the named
recipient, and may contain information that is confidential or privileged. If
you are not the intended recipient, you are hereby notified that any
disclosure, copying, distribution or use of the contents of this message is
strictly prohibited. If you have received this message in error or are not the
named recipient(s), please notify us immediately by contacting the sender at
the electronic mail address noted above, and delete and destroy all copies of
this message. Thank you.
TBHC_DISC
Confidentiality Notice: This e-mail message, including any attachments, is for
the sole use of the intended recipient(s) and may contain confidential and
privileged information. Any unauthorized review, use, disclosure or
distribution is prohibited. If you are not the intended recipient, please
contact the sender by reply e-mail and destroy all copies of the original
message.
Confidentiality Notice:
This e-mail, including any attachments is the property of Trinity Health and is
intended for the sole use of the intended recipient(s). It may contain
information that is privileged and confidential. Any unauthorized review, use,
disclosure, or distribution is prohibited. If you are not the intended
recipient, please delete this message, and reply to the sender regarding the
error in a separate email.